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Nuclear signaling by the APP intracellular domain occurs
predominantly through the amyloidogenic processing pathway
Abstract
Proteolytic processing of the amyloid precursor protein (APP) occurs via two alternative pathways,
localized to different subcellular compartments, which result in functionally distinct outcomes. Cleavage
by a beta-gamma sequence generates the Abeta peptide that plays a central role in Alzheimer's disease.
In the case of alpha-gamma cleavage, a secreted neurotrophic molecule is generated and the Abeta
peptide cleaved and destroyed. In both cases, a cytosolic APP intracellular domain (AICD) is generated.
We have previously shown that coexpression of APP with the APP-binding protein Fe65 and the histone
acetyltransferase Tip60 results in the formation of nuclear complexes (termed AFT complexes), which
localize to transcription sites. We now show that blocking endocytosis or the pharmacological or genetic
inhibition of the endosomal beta-cleavage pathway reduces translocation of AICD to these nuclear AFT
complexes. AICD signaling further depends on active transport along microtubules and can be
modulated by interference with both anterograde and retrograde transport systems. Nuclear signaling by
endogenous AICD in primary neurons could similarly be blocked by inhibiting beta-cleavage but not by
alpha-cleavage inhibition. This suggests that amyloidogenic cleavage, despite representing the minor
cleavage pathway of APP, is predominantly responsible for AICD-mediated nuclear signaling.
3703Research Article
Introduction
Regulated intramembrane proteolysis (RIP) by the γ-secretase
complex cleaves type I transmembrane proteins to release the
intracellular domain that can subsequently translocate to the
nucleus to regulate transcription (Fortini, 2002). As a prerequisite
to γ-secretase-mediated cleavage, the large extracellular domain
is proteolytically shed into the extracellular space. In the case of
the amyloid precursor protein (APP), two alternative cleavage
pathways exist, each generating different biological effects. In the
amyloidogenic pathway, sequential cleavages are performed by
the β-secretase BACE1 and the γ-secretase complex, generating
the Aβ peptide that oligomerizes, inhibits synaptic activity, has
neurotoxic properties, and aggregates into β-amyloid plaques
(Hardy and Selkoe, 2002; Walsh et al., 2002). The Aβ peptide
plays a central role in the pathology of Alzheimer’s disease (AD),
as has been formulated in the amyloid cascade hypothesis (Hardy
and Higgins, 1992). Besides β-secretase cleavage, ectodomain
shedding of APP can also be executed by α-secretases, including
ADAM10 and TACE. This cleavage occurs inside the Aβ domain,
thereby precluding the generation of toxic Aβ peptides. In
addition, α-cleavage generates a soluble extracellular fragment
(sAPPα) that has neurotrophic and neuroprotective activities
(Mattson et al., 1993). These opposing biological outcomes
of RIP processing for APP are so far unique amongst the described
RIP substrates.
The subcellular localization and trafficking of APP strongly
influences its mode of processing. Aβ secretion is greatly reduced
in Chinese Hamster Ovary (CHO) cells expressing APP with a
deletion of the YENPTY sequence necessary for endocytosis (Koo
and Squazzo, 1994; Perez et al., 1999). The endocytosis of APP
has been shown to occur after its accumulation with BACE1 in
lipid rafts, and the production of Aβ is cholesterol-dependent
(Ehehalt et al., 2003). Expression of dominant-negative dynamin
to block endocytosis reduced Aβ and simultaneously increased APP
levels at the plasma membrane and increased sAPPα secretion
(Carey et al., 2005; Ehehalt et al., 2003). By contrast, the
enhancement of endocytosis by overexpression of Rab5 favors Aβ
production (Grbovic et al., 2003). A recent report has demonstrated
that sAPPβ, the extracellular domain generated by β-secretase
cleavage, resides in endosomes. This suggests that β-cleavage occurs
after endocytosis of APP from the cell surface (Rajendran et al.,
2006), in line with the reported endosomal localization and acidic
pH optimum of BACE1 activity (Huse et al., 2000; Lin et al., 2000;
Vassar et al., 1999). Analysis of APP-BACE1 interactions by
fluorescence resonance energy transfer (FRET) has further
confirmed that the strongest association between APP and BACE1
occurs within endosomes (Kinoshita et al., 2003). Finally, analysis
of late endosomes by microscopy detected the presence of APP,
suggesting that a fraction of endocytosed APP is not recycled to
the plasma membrane (Ferreira et al., 1993; Rajendran et al., 2006).
Proteolytic processing of the amyloid precursor protein (APP)
occurs via two alternative pathways, localized to different
subcellular compartments, which result in functionally distinct
outcomes. Cleavage by a β-γ sequence generates the Aβ peptide
that plays a central role in Alzheimer’s disease. In the case of
α-γ cleavage, a secreted neurotrophic molecule is generated and
the Aβ peptide cleaved and destroyed. In both cases, a cytosolic
APP intracellular domain (AICD) is generated. We have
previously shown that coexpression of APP with the APP-
binding protein Fe65 and the histone acetyltransferase Tip60
results in the formation of nuclear complexes (termed AFT
complexes), which localize to transcription sites. We now show
that blocking endocytosis or the pharmacological or genetic
inhibition of the endosomal β-cleavage pathway reduces
translocation of AICD to these nuclear AFT complexes. AICD
signaling further depends on active transport along
microtubules and can be modulated by interference with both
anterograde and retrograde transport systems. Nuclear
signaling by endogenous AICD in primary neurons could
similarly be blocked by inhibiting β-cleavage but not by α-
cleavage inhibition. This suggests that amyloidogenic cleavage,
despite representing the minor cleavage pathway of APP, is
predominantly responsible for AICD-mediated nuclear
signaling.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/122/20/3703/DC1
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In contrast to endosomal β-cleavage of APP, the production of
sAPPα occurs at the plasma membrane (Sisodia, 1992) and is
enhanced when endocytosis is inhibited and APP accumulates at
the plasma membrane (Carey et al., 2005; Ehehalt et al., 2003;
Neumann et al., 2006).
Following ectodomain shedding by α- or β-secretase, the
membrane-bound α- and β-stubs are multiply cleaved by the γ-
secretase complex, whereby the primary ε-cleavage releases the APP
intracellular domain (AICD) (Fukumori et al., 2006; Kakuda et al.,
2006). Because γ-secretase is present at the plasma membrane
(Chyung et al., 2005; Tarassishin et al., 2004), in addition to
intracellular compartments such as endoplasmic reticulum (ER) and
Golgi (Annaert et al., 1999), AICD can also be generated at the
plasma membrane, spatially distinct from AICD generated after β-
γ cleavage in the endosomal system.
AICD has a short half-life and is rapidly degraded (Cupers et
al., 2001), for instance by insulin-degrading enzyme (Edbauer et
al., 2002). We therefore hypothesized that AICD generated by
sequential α-γ or β-γ-cleavages would have different propensities
for translocating to the nucleus. The APP-binding protein Fe65
stabilizes AICD (Kimberly et al., 2001) and stimulates the
transactivating activity of AICD in Gal4-promoter luciferase assays
(Cao and Sudhof, 2001). We have previously shown that AICD is
transported to the nucleus by Fe65 where together they bind Tip60,
localize into spherical nuclear complexes (termed AFT complexes),
and regulate transcription (Konietzko et al., 2008; von Rotz et al.,
2004).
To determine the contribution of α- and β-secretase-mediated
processing of APP to nuclear signaling by AICD, we analyzed the
formation of nuclear AFT complexes while biasing APP processing
towards either α- or β-cleavage pathways using genetic and
pharmacological approaches. Furthermore, we blocked endocytosis
to enhance α-cleavage and prevent β-secretase processing, and
manipulated both active retrograde and anterograde transport
systems. Finally, we analyzed the effect of secretase inhibition on
the nuclear translocation of endogenous AICD in primary neurons.
Together, our results point towards the endosome-based β-secretase-
mediated processing pathway of APP in generating AICD capable
of nuclear signaling.
Results
We have previously shown that AICD cleaved from APP
translocates to the nucleus bound to Fe65, forms spherical nuclear
AFT complexes together with Tip60, and is transcriptionally active
(Konietzko et al., 2008; von Rotz et al., 2004). Here, we determined
the nuclear signaling capability of AICD by analyzing the formation
of AFT complexes, while influencing subcellular trafficking and
proteolytic processing of APP through both genetic and
pharmacological manipulations.
Inhibition of endocytosis blocks nuclear translocation of AICD
Dynamin GTPase is central in the pinching-off of vesicles during
endocytosis and thus plays a role in the transfer of cell-surface APP
to endosomes, where BACE1 cleavage is dominant (Carey et al.,
2005; Kinoshita et al., 2003). The K44A dynamin mutant, where
the GTP-binding consensus sequence is altered, acts in a dominant-
negative fashion to inhibit endocytosis when overexpressed
(Herskovits et al., 1993). The dominant-negative dynamin indeed
inhibited endocytosis of holotransferrin, as shown by the reduced
uptake in the Dyn K44A-expressing cells (supplementary material
Fig. S1). HEK293 cells were transfected with APP, tagged with
Citrine at the C-terminus, and with N-terminally Myc-tagged Fe65
and CFP-Tip60, which led to nuclear AFT complex formation. To
manipulate endocytosis, we additionally transfected either wild-type
or K44A mutant dynamin, both fused to a hemagglutinin (HA) tag
to enable detection. Analysis by confocal microscopy revealed that
cells expressing wild-type dynamin were capable of forming AFT
complexes (Fig. 1A). Compared to wild-type dynamin, the number
of nuclei with AFT complexes was strongly reduced when K44A
dynamin was co-transfected (Fig. 1B). The block of nuclear AICD
translocation only occurred at higher expression levels of the
dominant-negative mutant (Fig. 1B, lower panel). Therefore, in cells
transfected with all four constructs, the expression of K44A mutant
dynamin might not always attain levels sufficient to compete with
endogenous dynamin and block endocytosis. Quantification of the
number of cells with AFT complexes nevertheless revealed a
significant reduction in AFT complexes in cells expressing K44A
mutant dynamin compared to the wild-type construct (Fig. 1C) [n=4,
Mann-Whitney U test (MWU) P<0.05].
Inhibition of endocytosis reduces β-cleavage of APP
To investigate the effects of inhibiting endocytosis on the β-cleavage
of APP, we utilized a cell line with stable expression of APP that
was labeled at its C-terminus with a triple HA tag, and analyzed
protein levels of the β-cleaved C-terminal fragment of APP (β-CTF).
Cells were transfected with wild-type or K44A mutant dynamin,
or with mRFP as a transfection control, and treated with the γ-
secretase inhibitor DAPT for 22 hours to accumulate APP CTFs.
Western blot analysis revealed a significant reduction in the amount
of β-CTF after inhibition of endocytosis through expression of
K44A dynamin, whereas levels of full-length APP remained
unchanged (Fig. 2A,B) (n=3, MWU, P<0.05). In addition, we
transfected HeLa cells with Swedish mutant APP (SwAPP) fused
to CFP, together with either GFP-tagged dominant-negative
dynamin, or GFP as a control. Using an antibody that specifically
detects sAPPβ generated from SwAPP (Rajendran et al., 2006), we
saw prominent labeling of endosomes in control transfected cells
(Fig. 2C). When endocytosis was inhibited in cells transfected with
the K44A dynamin mutant, the generation of sAPPβ was greatly
reduced (Fig. 2D). Inhibiting endocytosis therefore reduces β-
secretase cleavage of APP and nuclear signaling by AICD.
BACE1 inhibition reduces AFT complex formation, whereas
enhancing β-cleavage increases nuclear signaling by AICD
In order to manipulate β-secretase-mediated cleavage of APP, we
biased APP processing towards the non-amyloidogenic pathway
using a BACE1 inhibitor. A tripeptide-based inhibitor with an IC50
of 700 nM, previously tested in cell culture (Abbenante et al., 2000),
was applied in a dilution series, ranging from twofold IC50 down
to DMSO vehicle only. A HEK293 cell-line constitutively
expressing APP-Citrine was co-transfected with Fe65 and Tip60.
With increasing concentration of BACE1 inhibitor, the formation
of nuclear AFT complexes was reduced (correlation coefficient,
–0.984) (Fig. 3A). This reduction was found to be significant in
the twofold-IC50-treated cells compared to the vehicle-treated
control (n=3, MWU P<0.05). In order to monitor whether the
inhibitor concentrations used resulted in the inhibition of BACE1,
we treated wild-type HEK293 cells using the same dilution series
as for the fluorescence microscopy experiments. Cells were treated
concomitantly with the γ-secretase inhibitor DAPT in order to
accumulate levels of APP CTFs. Western blot analysis using an
APP C-terminal antibody revealed a clear reduction in the β-CTF
Journal of Cell Science 122 (20)
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to α-CTF ratio with increasing inhibitor concentrations, verifying
that the dilution series encompassed the relevant range (Fig. 3B).
In order to show that the endocytic BACE1 cleavage is
responsible for AICD signaling, we repeated these experiments
using a sterol-linked membrane-anchored β-secretase inhibitor
(Rajendran et al., 2008) that is targeted to early endosomes and
specifically inhibits endosomally localized BACE1. HEK293 cells
were transfected with APP, Fe65 and Tip60, followed by 16 hours
of treatment with 1 μM sterol-linked inhibitor. Formation of AFT
complexes was significantly reduced in cells treated with BACE1
inhibitor compared to DMSO-treated controls (Fig. 3C) (n=3, MWU
P<0.05). To assess the effects of the sterol-linked inhibitor on APP
processing, HEK293 cells with stable expression of APP-3HA were
treated with or without inhibitor for 16 hours and the protein lysates
analyzed by western blotting. There was a dramatic reduction in β-
CTF levels after inhibitor treatment, which was seen most clearly
in cells treated concomitantly with the γ-secretase inhibitor DAPT
(Fig. 3D).
Because the inhibition of β-secretase has been shown to reduce
AICD-mediated nuclear signaling, increasing BACE1 cleavage of
APP might be expected to have the reverse effect. The Swedish
mutation of APP, reported in specific cases of familial AD, has a
higher affinity for BACE1 and consequently results in greater
production of β-CTFs (Citron et al., 1994; Haass et al., 1995). We
transfected cells with Citrine-labeled wild-type or Swedish mutant
APP, in addition to Tip60 and Fe65. Quantification of the number
of cells with nuclear AFT complexes revealed a significant increase
in cells expressing the Swedish mutant compared to wild-type APP
(Fig. 3E) (n=6, P<0.05, MWU). In addition, cells were transfected
with either wild-type APP-3HA or SwAPP-3HA and lysates
analyzed by western blotting. There was a clear increase in the level
of β-CTF generated by cells expressing the Swedish mutant (Fig.
3F), suggesting that increasing APP cleavage by BACE1 increased
AICD signaling.
Our results using pharmacological inhibition of BACE1 pointed
towards a role of the β-secretase-mediated cleavage pathway in
AICD-mediated nuclear signaling. In order to further determine the
physiological relevance of this finding, we utilized a genetic model
in which the BACE1 gene is inactivated. BACE1 knockout
fibroblasts, derived from BACE1-deficient mice (Dominguez et al.,
2005), were transfected with APP, Fe65 and Tip60 and their ability
to form AFT complexes was compared to wild-type fibroblasts using
confocal microscopy (Fig. 4A,B). Although fibroblasts show
markedly reduced transfection efficiencies in comparison to
HEK293 cells, we could clearly identify nuclear AFT complexes
in wild-type fibroblasts. By contrast, AICD nuclear signaling was
almost abolished in BACE1-deficient cells (Fig. 4C) (n=3, MWU
P<0.05). Therefore, β-secretase-mediated cleavage of APP appears
to be essential for AICD signaling to the nucleus and formation of
AFT complexes. Furthermore, in cells deficient in the α–secretase
ADAM10 we could also identify AFT complexes in the nucleus
(supplementary material Fig. S2). The transfection efficiency of
ADAM10 knockout fibroblasts was even lower than for wild-type
and BACE1 knockout fibroblasts, preventing a quantification of
cells harboring nuclear AFT complexes.
Fig. 1. Inhibition of endocytosis blocks nuclear translocation of AICD.
(A) Confocal microscopy of cells transfected with APP-Citrine (APP), Myc-
Fe65 (FE65) and CFP-Tip60 (Tip60), together with wild-type, HA-labeled
dynamin (dyn) shows clear formation of nuclear AFT complexes. Inserts are
magnified twofold. Scale bar: 13 μm. (B) Confocal microscopy of cells co-
transfected with dyn K44A mutant blocks the formation of nuclear AFT
complexes, despite the coexpression of APP, Fe65 and Tip60. Tip60 localizes
to nuclear speckle-like structures in contrast to the spherical spots where it co-
localizes with Fe65 and AICD. Imaging cells at twofold higher magnification
(lower panels) shows that a high expression of dominant-negative dynamin is
necessary to block nuclear signaling. AFT complexes are still observed in cells
with low dyn K44A expression (bottom row). Scale is 20 μm in B upper panels
(overview). (C) Quantification of AFT complex formation in cells co-
transfected with APP, Fe65 and Tip60, together with either wild-type (dyn) or
K44A mutant dynamin (dyn K44A). Values were normalized to the average
level of Cy3 fluorescence in cells transfected with wild-type dynamin. Error
bars represent s.e.m., n=4, *P<0.05, MWU.
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Translocation of AICD to the nucleus is mediated by active
retrograde transport
Because our results pointed strongly towards the endocytic β-
secretase-mediated processing pathway of APP as the mediator of
nuclear signaling, we analyzed the subcellular distribution of
endocytosed APP by performing antibody uptake experiments.
HEK293 cells were transfected with APP fused at the C-terminus
to three tandem HA tags and incubated with the 6E10 antibody that
binds between the β- and α-cleavage site of APP. Binding at 4°C,
to prevent endocytosis, showed prominent surface-labeling of
transfected cells (Fig. 5A). Following 6E10 binding, the cells were
incubated for 10 or 30 minutes at 37°C. After 10 minutes, there
was already 6E10 staining in vesicles close to the nucleus (Fig.
5B). At 30 minutes, the vast majority of the surface-bound 6E10
had been endocytosed and translocated to perinuclear regions, where
Journal of Cell Science 122 (20)
Fig. 2. Inhibition of endocytosis reduces β-cleavage of APP. (A) HEK293
cells, stably expressing C-terminally labeled APP-3HA, were transfected with
wild-type (Dyn) or K44A mutant dynamin (K44A), or mRFP as transfection
control (Ctrl), and treated with the γ-secretase inhibitor DAPT for 22 hours to
accumulate APP CTFs. Western blotting and staining were carried out using
anti-HA-tag antibody to detect levels of full-length APP and both α- and β-
CTFs, and 6E10 antibody to specifically detect β-CTFs. A reduction in βCTF
levels is clearly visible in cells expressing the K44A mutant.
(B) Quantification of β-CTF and full-length APP after transfection of cells as
described in A reveals a significant reduction in β-CTF levels after inhibition
of endocytosis with K44A dynamin. Levels of full-length APP are not
significantly altered. Error bars represent s.e.m., n=3, *P<0.05, MWU.
(C,D) HeLa cells were co-transfected with SwAPP-CFP and either dominant-
negative dyn K44A-GFP or GFP as a control. Staining with a polyclonal
antibody was used to detect the ectodomain of β-cleaved SwAPP (sAPPβ).
(C) GFP control-transfected cells show prominent generation of sAPPβ in
endosomal compartments. (D) Expression of dyn K44A prevents the
generation of sAPPβ. Scale bars: 10 μm.
Fig. 3. BACE1 inhibition reduces AFT complex formation, whereas enhancing
β-cleavage increases nuclear signaling by AICD. (A) HEK293 cells
transfected with wild-type human APP-Citrine, CFP-Tip60 and Myc-Fe65
were treated for 22 hours with DMSO vehicle only or with β-secretase
inhibitor at different concentrations (IC50=700 nM). Correlation between the
fold-IC50 and the number of cells containing AFT complexes was clearly
negative (–0.984). Inhibition relative to control was significant at twofold
IC50 (n=3, *P<0.05, MWU). (B) HEK293 cells expressing endogenous APP
were treated simultaneously with γ-secretase inhibitor (to accumulate CTFs)
and β-secretase inhibitor at the concentrations indicated. Western blotting with
an APP C-terminal antibody shows the inhibition of β-CTF formation around
and above the IC50 concentration. (C) HEK293 cells were transfected with
APP-Citrine, HA-Fe65 and CFP-Tip60, followed by 16 hours treatment with
1 μM sterol-linked BACE1 inhibitor. AFT complex formation was
significantly reduced in cells treated with BACE1 inhibitor compared to
DMSO-treated controls (Wt). n=3, *P<0.05, MWU. (D) Cells stably
expressing APP-3HA were treated with or without inhibitor for 16 hours and
total protein lysates analyzed by western blotting. Membranes were probed
using anti-HA-tag antibody to detect levels of full-length APP and both α- and
β-CTFs, and using 6E10 antibody to specifically detect β-CTFs. Levels of β-
CTFs are reduced dramatically after inhibitor treatment, which is especially
visible in cells treated concomitantly with 1 μM DAPT. (E) HEK293 cells
transfected with either wild-type (WtAPP) or Swedish mutant (SwAPP) APP-
Citrine, in addition to CFP-Tip60 and HA-Fe65. Quantification of the number
of cells with nuclear AFT complexes reveals a significant increase in AFTs in
cells expressing the Swedish mutant compared to wild-type APP. Error bars
represent s.e.m., n=6, *P<0.05, MWU. (F) Cells were transfected with either
wild-type APP-3HA or SwAPP-3HA and lysates analyzed by western blotting.
Analysis using APP C-terminal antibody, which detects both endogenous and
HA-labeled APP, reveals a strong increase in β-CTFs in cells expressing the
SwAPP mutant. Error bars represent s.e.m. in A, C and E. APPm, mature APP;
APPim, immature APP.
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it colocalized with APP detected via the HA tags (Fig. 5C).
Therefore, either full-length APP or β-CTFs, both detected by the
6E10 and anti-HA antibodies, are transported from the plasma
membrane to the vicinity of the nucleus.
To determine the involvement of active retrograde transport in
the perinuclear translocation of APP and β-CTFs, we disrupted the
dynein-dynactin complex. Dynactin is a multi-protein complex that
is involved in coordinating binding of cargo vesicles to dynein for
minus-directed transport along microtubules from the periphery to
the soma. Overexpression of p50 dynamitin (Burkhardt et al., 1997)
or p150Glued (Quintyne et al., 1999), both subunits of dynactin,
results in the uncoupling of the dynactin complex from dynein and
disruption of retrograde transport. We transfected cells with APP-
Citrine, HA-Fe65 and CFP-Tip60 to generate AFT complexes, and
additionally with either p50 dynamitin-GFP or p150Glued-mRFP
(only with coiled-coil domain 1; CC1); GFP and mRFP, respectively,
were used as control vectors. Analysis by confocal microscopy
revealed many cells expressing all four constructs. In the case of
cells overexpressing either of the dynactin components, nuclear AFT
complex formation was inhibited and Tip60 was localized to
Fig. 4. BACE1 knockout fibroblasts lack AICD-mediated
nuclear signaling. (A) Wild-type fibroblasts were
transfected with APP-Citrine, HA-Fe65 and CFP-Tip60
and analyzed by confocal microscopy. Images show clear
formation of spherical AFT complexes. (B) BACE1
knockout fibroblasts fail to show translocation of AICD-
Fe65 to the nucleus, and Tip60 resides in irregular
speckles when transfected as in A. Larger left images
show differential interference contrast and overlay of
fluorescent stainings with nuclear DRAQ5 staining.
Single fluorescent channels are shown in the cutouts on
the right. Scale bar: 13 μm. (C) Quantification of the
number of cells with AFT complexes reveals a near-
abolishment of AFT complex formation in the BACE1
knockout (BACE1 KO) fibroblasts compared to wild-type
(Wt). Error bars represent s.e.m., n=3, *P<0.05, MWU.
Fig. 5. APP is endocytosed from the plasma
membrane and transported to perinuclear
compartments. Live HEK293 cells transfected with
APP-3HA were incubated for 30 minutes at 4°C to
allow binding of 6E10 antibody to cell-surface APP.
(A) Confocal microscopy of cells fixed immediately
after the 4°C incubation. Staining for 6E10 reveals
strong surface binding on cells expressing APP-
3HA. (B) Incubation of cells at 37°C leads to the
endocytosis of surface APP together with the bound
6E10 antibody, with vesicles seen close to the
nucleus after 10 minutes. (C) After 30 minutes most
of the 6E10 has been translocated to perinuclear
compartments. Scale bar: 30 μm in A; 20 μm in B
and C.
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nuclear speckles. Additionally, APP and Fe65 were often seen to
accumulate in the processes (Fig. 6A). As observed with the
expression of dynamin mutants that inhibit endocytosis, a threshold
level of expression is necessary to inhibit cellular processes. We
determined the number of cells with AFT complexes with a
fluorescence microscope and found that coexpression of p50
dynamitin-GFP significantly reduced the formation of nuclear AFT
complexes when compared to coexpression of GFP as a control
(Fig. 6B) (n=4, P<0.05, MWU). Similarly, the disruption of
retrograde transport by p150Glued-mRFP expression resulted in
reduced formation of nuclear AFT complexes compared to that seen
with transfection of mRFP (Fig. 6C) (n=3, P<0.05, MWU).
To analyze the effect of inhibiting retrograde transport on β-
cleavage of APP, HEK293 cells with stable expression of APP-
3HA were transfected with either p50 dynamitin-GFP or p150Glued-
mRFP. mRFP was used as a transfection control. Western blot
analysis using 6E10 antibody revealed a reduction in the levels
of β-CTFs in cell lysates after the disruption of the dynein-dynactin
complex by the overexpression of either p50 dynamitin or
p150Glued (Fig. 6D). Therefore, inhibition of retrograde transport
both disrupts β-cleavage of APP and inhibits nuclear signaling by
AICD.
Targeting endosomes to the cell periphery blocks AICD-
mediated nuclear signaling
Having identified a role of active retrograde transport in nuclear
signaling by AICD, we hypothesized that modification of
anterograde transport or perturbation of the subcellular organization
of endosomes might also influence AICD signaling. Anterograde
transport is mediated by kinesin (KIF) motors; KIF16B is a
kinesin-3 motor that specifically transports endosomes to the plus
end of microtubules (Hoepfner et al., 2005). The overexpression
of KIF16B has been shown to relocate early endosomes to the cell
periphery, whereas the expression of dominant-negative KIF16B-
ΔN, which lacks the catalytic domain, causes the clustering of early
endosomes to the perinuclear region and delays receptor recycling
to the plasma membrane (Hoepfner et al., 2005). Expression of wild-
type KIF16B, labeled with yellow fluorescent protein (YFP),
showed a localization mostly in the cell periphery, whereas the YFP-
labeled dominant-negative mutant localized within the perinuclear
region of the cell (Fig. 7A). When coexpressed with APP, Fe65 and
Tip60, overexpression of wild-type KIF16B inhibited the formation
of nuclear AFT complexes, when viewed in the confocal
microscope, whereas dominant-negative KIF16B clearly enabled
AFT complex formation (Fig. 7B). When quantified, the number
of cells with AFT complexes was found to be significantly reduced
in cells treated with wild-type KIF16B, both compared to control
(mRFP-transfected) and dominant-negative KIF16B-transfected
cells (Fig. 7C) (n=4, MWU P=<0.05). There was, however, no
significant difference between control and KIF16B dominant-
negative treated cells, despite a trend towards an increase in AFT
numbers. To analyze the effects of KIF16B expression on APP
βCTF levels, HEK293 cells expressing APP-3HA were transfected
with KIF16B constructs or with mRFP as a control and additionally
treated for 22 hours with DAPT to prevent degradation of the APP
CTFs produced. Western blotting using both anti-HA and 6E10
antibodies revealed an increase in βCTFs in cells treated with
dominant-negative KIF16B. Further, there was both an increase in
αCTFs and a reduction in βCTFs in cells treated with wild-type
KIF16B (Fig. 7D). Therefore, overexpression of wild-type KIF16B
leads to a reduction of β-secretase-mediated cleavage of APP,
whereas expression of its dominant-negative form has the reverse
effect. Together, these data point to a role for perinuclear endosomes
in AICD nuclear signaling.
BACE1 inhibition in primary neurons inhibits endogenous
AICD nuclear signaling
Our results using both pharmacological and genetic inhibition of
BACE1 in HEK293 cells and fibroblasts highlighted an important
role for the β-secretase-mediated cleavage pathway of APP in AICD
Journal of Cell Science 122 (20)
Fig. 6. Nuclear translocation of AICD depends on active retrograde transport.
Overexpression of components of the dynactin complex block dynein-
mediated retrograde transport. (A) Confocal microscopy of HEK293 cells co-
transfected with APP-Citrine, CFP-Tip60, HA-Fe65 and p50 dynamitin-GFP.
Tip60 localizes to nuclear speckle-like compartments and nuclear translocation
of AICD is completely prevented. Accumulation of APP and Fe65 in the
processes is frequently observed (arrows). Scale bar: 10 μm. (B) Cells were
transfected with APP-Citrine, CFP-Tip60, HA-Fe65 and either p50 dynamitin-
GFP or GFP as a control. Quantification of cells with AFT complexes shows a
significant reduction when retrograde transport is inhibited by the expression
of p50 dynamitin. Error bars represent s.e.m., n=4, *P<0.05, MWU. (C) Cells
were transfected as in B to generate AFT complexes with co-transfection of
either RFP-p150glued CC1 domain, to inhibit retrograde transport, or RFP as a
control. Quantification of cells with AFT complexes shows a significant
reduction when retrograde transport is inhibited by the expression of p150glued
CC1. Error bars represent s.e.m., n=3, *P<0.05, MWU. (D) HEK293 cells
expressing APP-3HA were transfected with either p50 dynamitin-GFP or
p150glued CC1-RFP. mRFP was used as a transfection control. Cells were
treated for 22 hours with 1 μM DAPT and total cell lysates analyzed by
western blotting. Membranes were probed using 6E10 antibody to detect
levels of full-length APP and β-CTFs. Cells transfected with either p50
dynamitin or p150glued show reduced levels of β-CTFs compared to mRFP-
transfected cells.
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nuclear signaling. In order to further confirm the physiological
relevance of our findings, we analyzed the occurrence of
endogenous AICD in the nuclei of primary neurons. We have
previously shown the formation of endogenous nuclear AICD spots
to be enhanced through the inhibition of nuclear export using
leptomycin B (LMB) (Konietzko et al., 2008). Primary neuronal
cultures, isolated from postnatal day zero C57/Bl6 mice, were
treated after 14 days in vitro (DIV 14) with 20 ng/ml LMB for 22
hours, followed by nuclei preparation and immunoprecipitation.
Western blotting and staining using anti APP C-terminal antibody
revealed a marked increase in the levels of AICD detected after
LMB treatment compared to control conditions (Fig. 8A). To
visualize endogenous AICD in the nucleus of primary neurons by
confocal microscopy we therefore treated cultures with LMB in
addition to various secretase inhibitors. Similar to what we observed
using rat neurons (Konietzko et al., 2008), the result of LMB
treatment was an increased number of nuclear spots staining for
AICD (Fig. 8B,D).
Because APP staining in the cytosol labels vesicles with similar
dimensions as nuclear spots and because APP is also present in the
perinuclear endoplasmic reticulum, it is essential to identify a mid-
nuclear plane in the confocal microscope for analysis. We stained
neurons with DRAQ5 to label nuclei and in addition with Map2ab
to label the neuronal microtubular cytoskeleton. Taking confocal
sections with 1-μm steps in the z-axis, we saw that the Map2ab
staining more faithfully reveals the mid-nuclear plane (Fig. 8B).
Whereas in the middle panel (1 μm below the mid-nuclear plane)
the DRAQ5 staining still reveals nuclear dimensions similar to the
first panel, the staining for Map2ab shows that the nuclear edges
are already overlaid with microtubules. AICD spots identified in
this section could therefore represent cytosolic APP. We thus chose
to select mid-nuclear confocal planes via the Map2ab staining (Fig.
8B, plane of first panel) before imaging the AICD and nuclear
stainings.
To determine the influence of the β-secretase cleavage pathway
on the occurrence of endogenous nuclear AICD spots, primary
neurons were treated with pharmacological inhibitors to modulate
cleavage of either α- or β-secretase. In order to test the efficiency
of commercially available inhibitors, neurons were treated for 22
hours at DIV 14 with 20 μM of the α-secretase inhibitor TAPI 1,
or with 60 nM BACE1 inhibitor A, or with 1.4 μM BACE1 inhibitor
B. In addition, cells were treated concomitantly with 1 μM γ-
secretase inhibitor DAPT to accumulate CTFs. As expected,
treatment with TAPI 1 resulted in a reduction in α-CTF levels,
whereas treatment with either BACE1 inhibitor A or B resulted in
a reduction in β-CTFs, when compared to treatment with DAPT
alone (Fig. 8C). Neurons were subsequently treated with the
different secretase inhibitors together with 20 ng/ml LMB for 22
hours, followed by staining with APP C-terminal and Map2ab
antibodies, and analysis by confocal microscopy (Fig. 8D).
Neurons were identified by the Map2ab staining that also guided
the identification of the optimal mid-nuclear plane as described
above. Single confocal sections from 19-42 neurons were imaged
for each condition (control, n=19; LMB, n=35; DAPT + LMB, n=34;
TAPI 1 + LMB, n=42; BACE1 inhibitor A + LMB, n=38; BACE1
inhibitor B + LMB, n=22). The nuclei were outlined with the help
of the Map2ab staining, and the number of AICD spots quantified
by two independent researchers blinded to the experimental
conditions (Fig. 8E). After treatment with LMB an increased number
of AICD spots was clearly visible in the nucleus, which was not
significantly reduced by TAPI 1 co-treatment. By contrast, treatment
of neurons with DAPT, which prevents AICD generation, or with
either of the BACE1 inhibitors resulted in a significant inhibition
of nuclear AICD spot formation (MWU, P<0.001 versus LMB
alone). Thus, the inhibition of β-secretase was sufficient to prevent
nuclear signaling of endogenous AICD in neurons, whereas α-
secretase inhibition had no effect.
Fig. 7. Targeting endosomes to the cell periphery blocks AICD-mediated
nuclear signaling. (A) KIF16B is the motor protein responsible for anterograde
transport of endosomes. Overexpression of wild-type KIF16B-YFP (KIFWt)
in HEK293 cells shows localization mostly in the cell periphery, whereas
expression of KIF16B-ΔN-YFP (KIFDN) is predominantly localized within
the perinuclear region. Left panels show differential interference contrast;
middle panels the YFP fluorescence; and right panels the overlay of YFP with
DAP1-labeled nuclei. Cells were counterstained with DAPI to label nuclei.
(B) Confocal microscopy of HEK293 cells transfected with APP, Fe65, Tip60
and KIF16B constructs. Overexpression of wild-type KIF16B inhibits the
formation of nuclear AFT complexes, whereas dominant-negative KIF16B
clearly enables formation of AFT complexes. Left panels show differential
interference contrast, and far right panels the overlay of the fluorescent
stainings. Scale bars: 13 μm. (C) Quantification reveals the number of cells
with AFT complexes to be significantly reduced in cells treated with wild-type
KIF16B, both compared to control (mRFP-transfected) and dominant-negative
KIF16B-transfected cells. Error bars represent s.e.m., n=4, *P<0.05, MWU.
(D) Analysis of the effect of wild-type and dominant-negative KIF16B
expression on APP βCTF levels. HEK293 cells expressing APP-3HA were
transfected with KIF16B constructs or with mRFP as control and additionally
treated for 22 hours with DAPT to accumulate APP CTFs. Western blotting
and staining were carried out using anti-HA-tag antibody to detect full-length
APP and both α- and β-CTFs, and using 6E10 antibody to specifically detect
β-CTFs. To control for transfection efficiency, KIF16B-YFP constructs were
detected using GFP antibody. Levels of β-CTF are increased in cells
overexpressing dominant-negative KIF16B. In cells overexpressing wild-type
KIF16B, levels of β-CTF are reduced, whereas levels of α-CTF are increased.
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Discussion
The physiological outcomes of α- or β-secretase-initiated processing
of APP are distinct. We have now shown that this dichotomy holds
up for AICD nuclear signaling. The β-secretase-mediated cleavage
of APP in endosomal compartments is mainly responsible for
generating AICD species that are capable of translocating to the
nucleus, and active transport of endosomes to the perinuclear region
is a prerequisite for nuclear signaling.
RIP-mediated generation of cytosolic fragments of type I
transmembrane proteins is emerging as a widely used pathway for
directly transmitting a signal from the plasma membrane to the
nucleus (Fortini, 2002). It has been demonstrated that AICD
possesses transactivation activity in luciferase assays (Cao and
Sudhof, 2001), controls the expression of endogenous target genes
(Alves da Costa et al., 2006; Baek et al., 2002; Belyaev et al., 2009;
Liu et al., 2007; Muller et al., 2006; Pardossi-Piquard et al., 2005;
Schrenk-Siemens et al., 2008; von Rotz et al., 2004; Zhang et al.,
2007) and, together with Fe65 and Tip60, localizes to spherical
nuclear complexes that are thought to represent sites of transcription
(Konietzko et al., 2008; von Rotz et al., 2004). AICD can be
generated from APP by two different proteolytic processing
pathways and we have analyzed their differential nuclear signaling
capacity. Non-amyloidogenic α-secretase processing occurs at the
plasma membrane, whereas β-secretase cleavage takes place in
endosomal compartments. AICD is rapidly degraded in the
cytoplasm (Cupers et al., 2001) and we hypothesized that the
subcellular location of AICD generation could therefore influence
its capacity for nuclear signaling (Miaczynska et al., 2004).
Inhibiting endocytosis with dominant-negative dynamin reduced
nuclear signaling by AICD, as determined by the reduced number
of cells forming nuclear AFT complexes. This means that AICD
generated directly at the plasma membrane by sequential α- and γ-
cleavages has a lower likelihood of translocating to the nucleus.
Endocytosis of APP from the plasma membrane has been reported
to lead to Aβ generation, and β-secretase processing has been shown
to occur in endosomes (Carey et al., 2005; Grbovic et al., 2003;
Rajendran et al., 2006). We confirmed these findings by showing
that blocking endocytosis prevents the generation of sAPPβ in
endosomal vesicles and strongly reduces the production of β-cleaved
C-terminal fragments of APP.
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Fig. 8. BACE1 inhibition in primary neurons inhibits
endogenous AICD nuclear signaling. (A) Primary neuronal
cultures, prepared from postnatal day zero C57/Bl6 mice,
were treated at DIV 14 with 20 ng/ml LMB, followed by
nuclei isolation and immunoprecipitation. Western blotting
with anti-APP C-terminal antibody shows a dramatic increase
in the level of AICD detected in the nuclear fraction after
LMB treatment. (B) Neurons treated with LMB were fixed in
methanol and stained for APP, Map2ab and DNA (DRAQ5).
Confocal sections were taken 1 μm apart in the z-axis. The
first panel shows the mid-nuclear plane, free of Map2ab
staining in the DRAQ5-stained nuclei (insert). Moving
towards the bottom of the cell the second panel still seems to
encompass the nucleus according to the DRAQ5 staining but
the Map2ab staining shows that microtubules already overlay
with the nuclear staining. The third panel shows the
microtubule network lying beneath the nucleus with APP
staining in vesicular structures. Scale bar: 7 μm. (C) Primary
neuronal cultures at 14 DIV were treated with 20 μM α-
secretase inhibitor TAPI 1, 60 nM BACE1 inhibitor A
(Calbiochem, #171601) or 1.4 μM BACE1 inhibitor B
(Calbiochem, #565749), together with 1 μM γ-secretase
inhibitor DAPT to accumulate CTFs. Western blots were
stained with APP C-terminal antibodies. Treatment with TAPI
1 leads to a reduction in levels of α-CTFs, whereas treatment
with either BACE1 inhibitor A or B leads to a reduction in β-
CTFs, when compared to DAPT treatment alone.
(D) Neuronal cultures at DIV 14 were treated with LMB for
22 hours and additionally with the different secretase
inhibitors as described in C. Cells were stained as in B and
single confocal sections were acquired in the mid-nuclear
plane as determined by the Map2ab staining. The upper row
shows an overlay of all three stainings whereas the lower row
is a twofold zoom of the APP staining. Treatment with either
LMB alone or in combination with TAPI1 results in a
relatively high frequency of AICD nuclear spots. By contrast,
treatment of neurons with DAPT or either BACE1 inhibitor A
or B reduces the frequency of nuclear AICD spots. Scale bar:
7 μm. (E) Quantification of the number of AICD spots per
nucleus reveals a significant reduction in the number of
nuclear AICD spots following treatment with either DAPT or
BACE1 inhibitors. *P<0.001 versus LMB alone, MWU.
Treatment of cells with TAPI 1 does not significantly alter the
number of nuclear AICD spots, when compared to LMB
treatment alone. Number of imaged neurons: control, n=19;
LMB, n=35; DAPT+LMB, n=34; TAPI 1+LMB, n=42;
BACE1 inhibitor A+LMB, n=38; BACE1 inhibitor B+LMB,
n=22, error bars represent s.e.m.
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To directly analyze the impact of β-cleavage on AICD-mediated
nuclear signaling, we inhibited BACE1 using two independent
pharmacological inhibitors that clearly suppressed the β-cleavage
of APP. Additionally, the inhibitors resulted in a dose-dependent
decrease in AICD nuclear signaling. The strong reduction in
nuclear AICD translocation is astonishing in light of the fact that
less than 10% of APP is processed along the amyloidogenic
pathway. We therefore performed experiments aimed at increasing
the amyloidogenic processing of APP. The familial Alzheimer’s
disease Swedish double mutation in APP has been shown to possess
a higher affinity for BACE1 and result in a greater production of
β-CTFs and Aβ peptides (Citron et al., 1994; Haass et al., 1995).
It has been previously suggested that β-cleavage of wild-type and
Swedish APP might localize to different subcellular compartments,
with wild-type cleavage occurring in the endosomal system and
SwAPP being cleaved in post-Golgi secretory vesicles (Haass et
al., 1995). By contrast, we have shown both APP and SwAPP β-
cleavage to be strongly reduced by inhibiting endocytosis. By
staining with antibodies specific for sAPPβ derived from SwAPP,
we could detect a clear inhibition of Swedish sAPPβ formation in
cells treated with dominant-negative dynamin. Our results further
support the current evidence that SwAPP β-cleavage also occurs
within the endosomal system (Rajendran et al., 2006; Rajendran et
al., 2008; Zou et al., 2007) and that interaction between BACE1
and SwAPP does not take place in the secretory pathway (Goldsbury
et al., 2006). Compared to wild-type APP, the Swedish mutation
resulted in a significant increase in AICD nuclear signaling. We
therefore propose that this effect is caused by an increased affinity
of SwAPP for BACE1, which results in a higher proportion of
APP cleavage within endosomal vesicles rather than by α-secretase
cleavage at the plasma membrane. Therefore, AICD-mediated
nuclear signaling can be both positively and negatively regulated
by the manipulation of BACE1 cleavage.
Analysis of AFT complex formation in fibroblasts derived from
mice deficient for BACE1 (Dominguez et al., 2005) showed nuclear
AICD signaling to be practically abolished in these cells. By contrast,
cells derived from ADAM10 knockout mice were still able to form
AFT complexes in the nucleus. Similar results were obtained when
analyzing endogenous AICD signaling in primary neurons. Inhibition
of nuclear export by LMB increased AICD in nuclear spots and this
could be blocked by two different β-secretase inhibitors, but not by
an inhibitor of α-secretase. Therefore, despite representing the minor
cleavage pathway of APP, only amyloidogenic processing generates
AICD capable of translocating to the nucleus.
If AICD generated at the plasma membrane following α-γ-
cleavage is degraded before it reaches the nucleus, then endocytosis
of APP should involve translocation to the nuclear vicinity before
γ-cleavage releases AICD. Antibodies bound to cell-surface APP
were endocytosed together with APP and could be detected in
perinuclear compartments 10 minutes after initiating endocytosis.
By 30 minutes, the entire surface-bound antibody accumulated close
to the nucleus. This rapid subcellular redistribution is probably
mediated by active retrograde transport of signaling endosomes,
which is more efficient than diffusion, even over relatively short
distances (Howe and Mobley, 2004). Active retrograde transport
of endocytic vesicles along microtubules is mediated by the dynein
motor and the associated dynactin complex (Schroer, 2004).
Overexpression of p50 dynamitin or the p150glued CC1 domain, both
components of the dynactin complex, disrupts retrograde transport
(Burkhardt et al., 1997; King et al., 2003) and we have shown that
this also leads to the disruption of nuclear AFT complex formation.
Nuclear signaling by AICD therefore depends upon dynein-
mediated retrograde transport and is reminiscent of neurotrophin
signaling in this respect. NGF- and BDNF-induced rapid nuclear
signaling by trkA and trkB receptors has been shown to rely on
dynein-based retrograde transport of signaling endosomes (Ehlers
et al., 1995; Watson et al., 1999) that can similarly be disrupted by
p50 dynamitin (Bhattacharyya et al., 2002). Recently, nuclear
translocation and subsequent gene regulation by the transcription
factor NF-κB has likewise been shown to be dependent on active
retrograde transport (Shrum et al., 2009).
Whereas retrograde transport targets endosomal vesicles to
perinuclear regions, anterograde transport along microtubules
delivers them to the cell periphery. The overexpression of KIF16B,
a member of the kinesin 3 family of motor proteins responsible for
anterograde transport of endosomes (Hoepfner et al., 2005), was
shown to diminish AFT complex formation. By reducing the number
of early endosomes in the perinuclear region, either by disrupting
the dynactin complex or by overexpressing kinesin motor proteins,
the likelihood of AICD being delivered to the vicinity of the nucleus
is diminished and its production at the plasma membrane, following
α-secretase cleavage, increases. The re-distribution of early
endosomes to the cell periphery might also lead to a reduced
residence time of APP and BACE1 together in early endosomes,
due to increased recycling to the plasma membrane, which could
explain the reduction in β-cleavage of APP following
overexpression of KIF16B. Thus, microtubule-based transport is
essential for AICD signaling and this might be disrupted in AD,
where axonal swellings with accumulated motor proteins have been
described early in the disease process (Stokin et al., 2005).
Cleavage of APP by α- and β-secretase-mediated processing has
different physiological outcomes and we have determined that the
β-pathway-mediated nuclear signaling is dependent upon fast
retrograde transport. In analogy, nerve growth factor (NGF)-trkA
interaction in the periphery promotes axonal outgrowth, but only
NGF-trkA complexes that are internalized and retrogradely
transported in signaling endosomes support neuronal survival
(Kuruvilla et al., 2004; Ye et al., 2003). The NGF signal increases
the retrograde transport of trkA-containing endosomes that also
transport activated ERK1 and ERK2 (Delcroix et al., 2003).
Neuronal activity has been shown to increase β-cleavage of APP
(Cirrito et al., 2005; Kamenetz et al., 2003) but the molecular
mechanisms allowing BACE1 to sense neuronal activity are
unknown. APP has been demonstrated to interact with APP on
adjacent cells (Soba et al., 2005), but whether this interaction has
ligand functions as shown for Notch-Delta (Lubman et al., 2004)
and Notch-Serrate (Klueg and Muskavitch, 1999) interaction is not
known. Interestingly, the trans-endocytosis of ligand-bound Notch
extracellular domain (ECD) has been found to be a prerequisite for
efficient processing and dissociation of Notch 1 intracellular domain
(NICD) and its subsequent nuclear localization (Klueg and
Muskavitch, 1999; Parks et al., 2000). It is therefore possible that
the release of AICD from APP is also controlled by ligand binding.
One such ligand, which has been described to bind APP and trigger
γ-secretase-dependent AICD release, is the GPI-linked recognition
molecule TAG1 (Ma et al., 2008). The influence of TAG1 on APP
cleavage is analogous to the interaction between GPI-linked Ephrin
A and EphA receptors at the cell surface, which has been shown to
promote the cleavage of Ephrin A by ADAM10, enabling contact-
dependent axon repulsion during neural development (Hattori et al.,
2000). Regulation of EphB-EphrinB interaction has alternatively been
shown to be dependent on endocytosis of the receptor-ligand complex
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from the cell surface (Marston et al., 2003; Zimmer et al., 2003). It
is therefore plausible that the interaction between TAG1 and APP
promotes its endocytosis, which, according to our data, would in turn
lead to elevated β-cleavage and enhanced AICD nuclear signaling.
Further support for the connection between AICD signaling and
the β-cleavage pathway comes from two recent publications. Ma
and colleagues have determined that enhanced synaptic plasticity
and learning and memory in APP-overexpressing mice is abolished
by the deletion of BACE1 (Ma et al., 2007). Moreover, the authors
identified AICD as the only APP-derived fragment that correlated
with the changes in synaptic plasticity. Secondly, using Gal4-
promoter luciferase assays in primary neurons, Hoey and colleagues
have shown inhibition of APP-Gal4-mediated luciferase activity
after treatment with a β-secretase inhibitor, but not after treatment
with TAPI 1 (Hoey et al., 2009). As we have discussed previously,
the transcription of luciferase from transiently transfected plasmids
that lack a nuclear localization sequence occurs in the cytosol
(Konietzko et al., 2008). Plasmids can enter the nucleus only after
nuclear membrane breakdown during mitosis, which does not occur
in differentiated neurons. Nevertheless, the plasmids are
retrogradely transported to the vicinity of the nucleus and thus are
only accessible for AICD-Gal4 that reaches the perinuclear space.
The data of Hoey and colleagues therefore provide clear support
for our findings that the endocytic β-secretase cleavage pathway
and retrograde transport are prerequisites for AICD nuclear
signaling.
Shuttling of AICD into the nucleus is promoted by APP-bound
protein complexes containing Fe65 (Kimberly et al., 2001; von Rotz
et al., 2004) and 14-3-3 γ (Sumioka et al., 2005) and inhibited by
the neuronal adaptor proteins X11/MINT, which compete with Fe65
for binding to APP (Lau et al., 2000; von Rotz et al., 2004). In
addition, the control of nuclear export can influence the level of
nuclear AICD signaling, because inhibition of nuclear export leads
to the accumulation of AICD in nuclear spots when Fe65 is
coexpressed (Konietzko et al., 2008; von Rotz et al., 2004). Nuclear
signaling by AICD can therefore be modulated by multiple signals
acting at different stages of the APP life cycle. It has been recently
demonstrated that stimulation of the β2-adrenergic or δ-opioid
receptors leads to agonist-induced endocytosis that traffics γ-
secretase to late endosomes and elevates Aβ and AICD levels (Ni
et al., 2007). In the light of our data showing that nuclear AICD
translocation relies upon endocytic β-γ processing, this signaling
can therefore probably also be regulated by neurotransmitters.
In summary, our data suggest that endocytic APP processing
along the amyloidogenic pathway generates AICD capable of
regulating transcription, whereas AICD generated by α-cleavage
at the plasma membrane is likely to be degraded before reaching
the nucleus (Fig. 9). Most APP is processed by α-secretase, even
in neurons that express the highest levels of BACE1. Thus,
regulating the rate of β-cleavage of APP will have profound effects
on nuclear signaling by AICD. Increased β-secretase processing of
APP leads to AD, which is attributed to the generation of Aβ
peptides. Because nuclear AFT complexes have been shown to
mediate transcription, and in particular to regulate genes linked to
AD pathology, the regulation of AICD-mediated nuclear signaling
could play a role in the disease process. Further investigation into
the biological function of AICD nuclear signaling will be necessary
to predict the outcome of BACE1 inhibition as a therapy to reduce
Aβ production in AD.
Materials and Methods
Cell culture
Human embryonic kidney cells (HEK293), mouse embryonic fibroblasts and HeLa
cells were cultured as previously described (Rajendran et al., 2006; von Rotz et al.,
2004). For transfection, Lipofectamine 2000 was used according to the manufacturer’s
protocol. Leptomycin B DAPT, TAPI 1, BACE1 inhibitors A and B were from
Calbiochem. Sterol-linked BACE1 inhibitor (Rajendran et al., 2008) was used at 1 µM.
Primary cell culture
Primary neuronal cultures were prepared from 1-day-old C57Bl/6 mouse pups.
Cortices and hippocampi were dissected, transferred into EBSS (Invitrogen) containing
20U Papain (BioConcept) for 20 minutes at 37°C and triturated in Dulbecco’s modified
Eagle’s medium (DMEM; Invitrogen) containing 10% horse serum. Cells were plated
at a density of 5000 cells/mm2 onto coverslips coated with poly-D-lysine (0.01%)
and laminin (1.5 µg/cm2). After 3 hours, the medium was changed to Neurobasal A
(Invitrogen) containing B27 (Invitrogen), 200 mM L-glutamine and 100 mM sodium
pyruvate. Cells were cultured for 14 days at 37°C, 5% CO2.
Expression constructs
Wild-type dynamin-HA, dominant-negative dynamin-K44A-HA and dynamin-K44A-
GFP (Herskovits et al., 1993); APP-Citrine, HA-Fe65, Myc-Fe65 and CFP-Tip60
(von Rotz et al., 2004); RFP-p150Glued (Quintyne et al., 1999); p50-dynamitin-GFP
(Burkhardt et al., 1997); wild-type KIF16B, dominant-negative KIF16B-ΔN (Hoepfner
et al., 2005). Site-directed mutagenesis, yielded SwAPP constructs (Citron et al., 1995).
CMV-promoter-driven expression vectors containing C-terminal in frame extensions
with the fluorescent protein Citrine or a triple HA tag were used for cloning. HEK293
cell lines expressing APP-3HA and APP-Citrine were developed by manual cell
sorting.
Live antibody incubation
HEK293 cells, transfected with HA-tagged APP, were incubated with 6E10 (1:100,
Signet) antibodies at 4°C for 30 minutes. Cells were either fixed immediately or
incubated further for 10 or 30 minutes at 37°C to allow endocytosis of APP-antibody
complexes.
Transferrin uptake experiments
Hela-SwAPP cells were transfected with control GFP or dynamin-K44A-GFP. After
6 hours, the cells were incubated with iron-loaded human rhodamine-transferrin (10
μg/ml) for 10 minutes at 37°C.
Immunocytochemistry
Immunocytochemistry was performed as previously described (Rajendran et al., 2006;
von Rotz et al., 2004). Mouse anti-Myc (Roche) rat anti-HA (Roche) and rabbit anti-
APP C terminus (Vingtdeux et al., 2007; Vingtdeux et al., 2005) antibodies were
applied at 1:100 dilution, mouse anti Map2ab (Sigma) at 1:200, and anti-sAPPβ as
described (Rajendran et al., 2006). Cy3 or Cy5-conjugated secondary antibodies
(Jackson Laboratories) were applied at 1:250 dilutions. Cells were embedded in
Mowiol. DRAQ5 (Biostatus) or DAPI (Sigma) were used to stain nuclei.
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Fig. 9. Schematic representation of nuclear signaling by AICD. APP is
synthesized in the ER, transported along the secretory pathway and targeted to
the plasma membrane (PM), where sequential cleavages by α- and γ-secretase
generate AICD, which is rapidly degraded. Alternatively, APP is taken up into
endocytic vesicles (EV), which are anterogradely and retrogradely transported
along microtubules (MT). Sequential cleavage of APP by β- and γ-secretases
in endosomes generates AICD, which, in the case of preceding retrograde
transport, occurs in close vicinity to the nucleus (N). The APP-binding protein
Fe65 transports AICD to the nucleus where, together with Tip60, they form
nuclear AFT complexes, which are involved in the transcription of AICD-
regulated genes.
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Nuclei isolation
Cells were homogenized on ice using 10 strokes in a dounce homogenizer in buffer
containing 20 mM HEPES (pH 7.4), 20 mM KCl, 2 mM MgCl2, 2 mM DTT, 1.5
mM PMSF, 5 mM Phenantroline, 3 mM EGTA, 250 μg/ml insulin, 0.5 mM
spermidine, 0.15 mM spermine, and Protease Inhibitor Cocktail (Roche). After
addition of 0.5% NP-40 and 0.25 M sucrose, homogenization was repeated for a
further 10 strokes before centrifugation for 10 minutes at 800 g.
Immunoprecipitation
Immunoprecipitations were carried out using anti-APP C-terminus and anti-Tip60
(Calbiochem) antibodies using standard protocols.
Western blotting
For western blotting, anti-HA antibody (1:1000; Roche), APP-C-terminal antibody
(1:2000; Sigma), 6E10 (1:500; Signet), Dynamin-1 antibody (1:200; Santa Cruz
Biotechnology) and anti-GFP (1:1000; Invitrogen) were used. Bands were visualized
by ECL (Pierce).
Fluorescence microscopy
Counting of cells containing nuclear AFT complexes was performed using a Leica
DM IRE2 inverted microscope by two independent researchers, blinded to the
transfection conditions. The total number of cells with AFT complexes was determined
and normalized for transfection efficiency by comparing the levels of Citrine, CFP
or Cy3 fluorescence. With 5104 cells plated per well, we identified between 25 and
600 cells with nuclear AFT complexes, depending on cell type and transfected
plasmids. Relative number of cells with AFT complexes (Fig. 3A) was calculated
by dividing the total number of cells with AFT complexes in a well by the total
number of cells with AFT complexes in the experiment.
Confocal microscopy
Images were acquired on a Leica TCS/SP2 confocal microscope (Leica, Wetzlar,
Germany) as described (von Rotz et al., 2004)
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